Deals
Divestments ×
Feb 2018
has divested the global rights to LEUKINE® and associated manufacturing assets to
Jul 2016
has divested nitrate product Russian and Ukranian rights to
a Pamplona Capital Management-backed company
Jun 2016
has divested its Tucson research facility and operations to
Feb 2016
has divested nitrate product rights in selected markets to
Mar 2015
has entered a major multi-component strategic alliance with